Half Life Series Calculator

Tabulating decay across successive half-lives turns an exponential curve into a geometric sequence that is easy to read off. Writing the elapsed time as a number of half-lives n = t / t-half, the surviving amount is simply N0 times one half raised to n, so the series runs 50 percent, 25 percent, 12.5 percent, 6.25 percent, 3.125 percent, and so on. The fractional form matters more than the units: because the ratio N/N0 depends only on n, the same table applies whether the quantity is grams of iodine-131, becquerel of activity, plasma concentration of a drug in mg/L, or counts per minute. Practitioners memorise a few anchor points. Ten half-lives leave about 0.098 percent, roughly one part in 1,024, which is the customary rule of thumb for when a radionuclide store can be released as ordinary waste. In clinical pharmacokinetics, five half-lives leave about 3 percent and a drug is treated as cleared; the same figure describes the approach to steady state on repeated dosing. The table assumes a single, isolated first-order process, and this is where it can mislead. If the daughter product is itself radioactive, the total activity of a sample does not follow the simple curve: the daughter grows in as the parent decays and, when the parent is much longer lived, the pair reaches transient or secular equilibrium in which daughter activity approaches parent activity rather than falling. Technetium-99m generators, where molybdenum-99 with a 66-hour half-life feeds a 6.01-hour daughter, are the everyday example. Biological systems add a second complication: an administered radionuclide is removed both by decay and by excretion, so the effective half-life obeys 1/T-eff = 1/T-physical + 1/T-biological and is always shorter than either. Non-radioactive analogues, such as drug elimination or chemical reaction half-lives, are only first-order over limited concentration ranges and can become zero-order once a clearance pathway saturates, as ethanol metabolism does.

The idea that radioactive intensity halves in a characteristic period came from Ernest Rutherford, who in 1900 measured the decay of the thorium emanation and reported that its activity fell by half about every minute, describing this as the half-value period. With Frederick Soddy at McGill University he generalised the exponential law in 1902 and 1903 into a theory of atomic transformation. Once the individual emanations had been sorted out, chemists recognised that the naturally occurring heavy radioelements form linked chains rather than isolated species, and by 1913 Soddy and Kasimir Fajans had stated the radioactive displacement laws that fixed how alpha and beta emission move a nuclide across the periodic table, allowing the three natural series headed by uranium-238, uranium-235, and thorium-232 to be assembled and shown to terminate in stable lead isotopes. Harry Bateman supplied the mathematics for the general case in 1910, publishing a set of coupled solutions that give the amount of every member of a decay chain as a function of time; the Bateman equations remain the standard tool for reactor inventory and medical generator calculations. The tabular half-life view spread far beyond nuclear physics after Torsten Teorell laid out compartmental pharmacokinetics in 1937 and the elimination half-life became a routine drug parameter, an approach carried into clinical practice through the mid-twentieth century. Half-life tables also underpin radiometric dating and radioactive waste classification, and evaluated half-life values are compiled today in the Evaluated Nuclear Structure Data File maintained by Brookhaven National Laboratory.